19-67) with a M:F sex ratio of 1.7. 18.5% of patients was infected with the HDV, a situation that concerned therefore almost onehalf of HBsAg(+) patients (47.2%). Overall, at least one of the viruses responsible for persistent liver infectious (HBV, HCV or HDV) was present in more than 81% of cases. Moreover, HBV-HCV coinfections were found in 13.6% and 7.2% of the whole series were, indeed, affected by a triple HBV-HCV-HDV infection. In total, one patient every four was infected with at least two viruses. Patients infected with Delta virus were characterized by a variety of salient features. HCC was diagnosed six years younger than other patients (54.0±8.3 vs 60.5±10.1 years, P=0.0041). They were also affected with larger tumors (75.7±9.6 vs 56.0±3.2, 0.0184). Liver cirrhosis tended to be almost universally present in these patients (95. 
